[Sarcoidosis with Cardiac Involvement and Monoclonal Gammopathy]
O O Voronkova1, O A Tsvetkova1, S N Avdeev1
1I.M. Sechenov First Moscow State Medical University (Sechenov University).
Kardiologiia
|May 13, 2020
Summary
This case study details an 8-year follow-up of pulmonary sarcoidosis with myocardial injury and a rare monoclonal gammopathy. It highlights diagnostic approaches for cardiac sarcoidosis in such complex cases.
Area of Science:
- Cardiology
- Pulmonology
- Hematology
Background:
- Presents a rare clinical case of pulmonary sarcoidosis with intrathoracic lymphadenopathy and progressive myocardial injury.
- Highlights the unusual co-occurrence of monoclonal gammopathy in a patient with cardiac sarcoidosis.
- Notes the absence of morphological signs of paraproteinemic hemoblastosis and amyloidosis.
Purpose of the Study:
- To present an 8-year clinical follow-up of a patient with pulmonary sarcoidosis, myocardial injury, and monoclonal gammopathy.
- To discuss the diagnostic workup for cardiac sarcoidosis in a patient with coexisting monoclonal gammopathy.
- To explore the potential origins of monoclonal gammopathy in this specific clinical context.
Main Methods:
- Clinical case presentation with an 8-year follow-up.
- Comprehensive diagnostic evaluation including imaging and laboratory tests.
- Morphological examination to rule out specific hematological conditions.
Main Results:
- Demonstrated a gradually progressing myocardial injury in the context of pulmonary sarcoidosis.
- Identified monoclonal gammopathy as a rare, specific feature of the case.
- Confirmed the absence of paraproteinemic hemoblastosis and amyloidosis through morphological analysis.
Conclusions:
- Cardiac sarcoidosis diagnosis requires a comprehensive approach, especially with rare comorbidities like monoclonal gammopathy.
- The co-occurrence of monoclonal gammopathy and cardiac sarcoidosis is exceptionally rare and warrants further investigation.
- Understanding the origination of monoclonal gammopathy is crucial for managing patients with cardiac sarcoidosis.
Related Concept Videos
Cardiomyopathy IV: Restrictive Cardiomyopathy
349
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
349
Cardiomyopathy III: Hypertrophic Cardiomyopathy
277
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
277
Cardiomyopathy I: Introduction and Classification
393
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
393
Cardiomyopathy II: Dilated Cardiomyopathy
330
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
330
Rheumatic Heart Disease I: Introduction
327
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
327
Myocarditis I: Introduction
273
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
273


